
Dosing for
KEYTRUDA

Immune-mediated
Adverse Reactions
Advanced Renal Cell Carcinoma
Metastatic or Unresectable, Recurrent (M/uR) HNSCC
Melanoma: Advanced and Adjuvant
RECURRENT OR METASTATIC cSCC
Advanced Merkel Cell
Carcinoma
Advanced Urothelial
Carcinoma
High-Risk Non-muscle Invasive Bladder Cancer
Advanced Gastric
or
GEJ Cancer
Advanced Esophageal Squamous Cell Carcinoma
Relapsed or Refractory
Classical Hodgkin
Lymphoma
Refractory or
Relapsed
PMBCL
Advanced MSI-H/dMMr
Cancers
Advanced Hepatocellular Carcinoma
Advanced Triple-Negative Breast Cancer